Solventum Corporation (FRA:KB7)

Market Cap	10.88B
Revenue (ttm)	7.69B
Net Income (ttm)	350.65M
Shares Out	n/a
EPS (ttm)	2.01
PE Ratio	31.02
Forward PE	12.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6
Average Volume	64
Open	62.00
Previous Close	62.40
Day's Range	62.00 - 62.00
52-Week Range	47.60 - 80.50
Beta	n/a
RSI	45.93
Earnings Date	Aug 7, 2025

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wr...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KB7

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD